The psychotropic effectso fPsilocybe "magic" mushroomsa re caused by the l-tryptophan-derived alkaloid psilocybin.D espite their significance,t he secondary metabolome of these fungi is poorly understood in general. Our analysis of four Psilocybe speciesi dentified harmane, harmine, and ar ange of other l-tryptophan-derived b-carbolines as their natural products,w hichw as confirmed by 1D and 2D NMR spectroscopy.S table-isotope labeling with 13 C 11 -l-tryptophan verifiedt he b-carbolines as biosynthetic products of these fungi. In addition, MALDI-MS imaging showedt hat b-carbolines accumulate toward the hyphal apices.A sp otent inhibitors of monoamine oxidases, b-carbolines are neuroactive compounds and interfere with psilocybin degradation. Therefore, our findings represent an unprecedented scenario of natural product pathways that diverge from the same buildingb lock and produce dissimilar compounds, yet contribute directlyo ri ndirectly to the same pharmacological effects.

Figure 3. Characterization of P. cubensis SahH.Michaelis-Menten kinetics of SahH A) in hydrolytic direction (SAH as substrate),a nd synthetic direction with B) AdoorC )HCy as substrates.D)Impact of free NAD + on SahH activity.Catalytic activity in samples not supplemented with NAD + is probably due to carryover of enzyme-boundco-substrate from the heterologous protein production host.

Psilocybe magic mushrooms are best known for their main natural product, psilocybin, and its dephosphorylated congener, the psychedelic metabolite psilocin. Beyond tryptamines, the secondary metabolome of these fungi is poorly understood. The genomes of five species (P. azurescens, P. cubensis, P. cyanescens, P. mexicana, and P. serbica) were browsed to understand more profoundly common and species-specific metabolic capacities. The genomic analyses revealed a much greater and yet unexplored metabolic diversity than evident from parallel chemical analyses. P. cyanescens and P. mexicana were identified as aeruginascin producers. Lumichrome and verpacamide A were also detected as Psilocybe metabolites. The observations concerning the potential secondary metabolome of this fungal genus support pharmacological and toxicological efforts to find a rational basis for yet elusive phenomena, such as paralytic effects, attributed to consumption of some magic mushrooms.